Global Cardiac Surgery Team Comparing HES vs Albumin

Comparison of 6% Hydroxyethyl Starch 130/0.4 vs 5% Albumin in Cardiopulmonary Bypass for Cardiac Surgery

This meta-analysis of 12 studies (908 patients) compares 6% hydroxyethyl starch (HES 130/0.4) and 5% albumin in cardiac surgery with cardiopulmonary bypass. Results show no significant differences in blood loss, transfusion needs, ICU stay, or mortality. However, HES is associated with a significantly higher risk of acute kidney injury, raising concerns about its renal safety despite similar overall efficacy.

Read More »
Cybersecurity as it relates to perfusion

Cybersecurity as It Relates to Perfusion

Cybersecurity is increasingly critical in perfusion as connected medical devices expand vulnerability within hospital networks. Perfusionists must understand risks associated with the Internet of Medical Things (IoMT), adopt strong digital practices, and collaborate with IT teams. The article highlights downtime preparedness, device security awareness, and standardized guidelines to protect patient data and maintain safe clinical operations.

Read More »